share_log

SD: Specialized disclosure report

SD: Specialized disclosure report

SD:專項披露公告
美股sec公告 ·  05/17 11:33
Moomoo AI 已提取核心訊息
Novo Nordisk A/S, a leading healthcare company, has filed its Specialized Disclosure Report (Form SD) with the United States Securities and Exchange Commission. The report, which covers the period from January 1 to December 31, 2023, details the company's compliance with Rule 13p-1 under the Securities Exchange Act concerning conflict minerals. The Conflict Minerals Report, which is a key component of the filing, is available for public access on Novo Nordisk's website. This annual disclosure is part of the company's commitment to sustainable business practices and governance. The report was signed by Executive Vice President & Chief Financial Officer, Karsten Munk Knudsen, on May 17, 2024.
Novo Nordisk A/S, a leading healthcare company, has filed its Specialized Disclosure Report (Form SD) with the United States Securities and Exchange Commission. The report, which covers the period from January 1 to December 31, 2023, details the company's compliance with Rule 13p-1 under the Securities Exchange Act concerning conflict minerals. The Conflict Minerals Report, which is a key component of the filing, is available for public access on Novo Nordisk's website. This annual disclosure is part of the company's commitment to sustainable business practices and governance. The report was signed by Executive Vice President & Chief Financial Officer, Karsten Munk Knudsen, on May 17, 2024.
領先的醫療保健公司Novo Nordisk A/S已向美國證券交易委員會提交了其專業披露報告(SD表格)。該報告涵蓋2023年1月1日至12月31日期間,詳細介紹了該公司遵守《證券交易法》中有關衝突礦產的第13p-1條的情況。《衝突礦產報告》是該文件的重要組成部分,可在諾和諾德的網站上向公衆公開。該年度披露是公司對可持續商業行爲和治理的承諾的一部分。該報告由執行副總裁兼首席財務官卡斯滕·蒙克·克努森於2024年5月17日簽署。
領先的醫療保健公司Novo Nordisk A/S已向美國證券交易委員會提交了其專業披露報告(SD表格)。該報告涵蓋2023年1月1日至12月31日期間,詳細介紹了該公司遵守《證券交易法》中有關衝突礦產的第13p-1條的情況。《衝突礦產報告》是該文件的重要組成部分,可在諾和諾德的網站上向公衆公開。該年度披露是公司對可持續商業行爲和治理的承諾的一部分。該報告由執行副總裁兼首席財務官卡斯滕·蒙克·克努森於2024年5月17日簽署。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息